Director, Trade Accounts - West jobs in United States
cer-icon
Apply on Employer Site
company-logo

Madrigal Pharmaceuticals · 1 day ago

Director, Trade Accounts - West

Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Director, Trade Accounts is responsible for customer relationship management, negotiations, contracting, and ensuring that organizational goals are met through collaboration with key internal stakeholders.

BiopharmaBiotechnologyMedical DevicePharmaceutical

Responsibilities

Develop breadth and depth of NASH disease state, Rezdiffra therapy and overarching Madrigal commercialization strategy knowledge
Administer, negotiate, and execute IDN contracts according to established goals, objectives and timelines
Responsible for building rapport / maintaining collaborative Madrigal partnerships with contracted IDN accounts (i.e., including but not limited to requirement setting, sourcing and contracting, and ongoing performance management)
Represent Madrigal, in collaboration with the Key Account Director (KAD) team, as a point of contact for contract focused activities for respective IDN accounts including travel to organizations and key conferences (i.e., Asembia, NASP, etc.) to conduct live business meetings
Collaborate closely with key field teams (i.e. KADs, Sales, MPS, etc.) on key initiatives and inquiries related to contracting status, timelines, escalations, etc
Consistently evaluate existing IDN channel opportunities with a focus on impact, and support initiatives related to enhancing the model
Create business plans focused on SMART goals and objectives aligned with key Madrigal leadership and Market Access Strategic Imperatives
Collaborate closely with Madrigal KAD team to proactively communicate IDN intel across Madrigal stakeholders
Manage IDN escalations by identifying innovative, collaborative, cross-functional and team driven solutions
Develop and communicate key messages to internal and external IDN partners
Collaborate with IDN, MPS, and Data Analytics counterparts to deliver measurable business outcomes and influence change management across internal teams focused on key performance indicators (KPIs)
Ensure highest level of ethics, quality, and compliance by demonstrating in depth knowledge of laws that govern market access and channel activities
Conduct all activities in compliance with all applicable federal, state and local laws and regulations and company policies

Qualification

Trade/Patient Support experienceDistribution strategyCustomer contractingData analysisPre-launch experienceCross-functional teamworkMS Office proficiencyCommunication skillsOrganizational skillsPresentation skills

Required

Bachelor's degree required
10+ years of related experience in the biopharma industry with a proven, consistent history of high performance in a broad range of customer-facing roles
10+ years of experience in Trade/Patient Support customer facing related roles with increasing responsibilities
Experience with distribution strategy and customer contracting
Ability to develop insights from data trends to improve program performance
Experience with pre-launch drugs and new product launches
Ability to work effectively within cross-functional teams and in an environment of rapid and constant change
Excellent written, organizational, verbal, presentation, and communication skills a must
Proficient in MS Office products including PowerPoint, Word, and Excel
Ability to travel as needed for role responsibilities

Preferred

Advanced degree in Business or Pharmacy

Benefits

Flexible paid time off
Medical
Dental
Vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family

Company

Madrigal Pharmaceuticals

twittertwittertwitter
company-logo
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Funding

Current Stage
Public Company
Total Funding
$1.94B
Key Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M

Leadership Team

leader-logo
Mardi C. Dier
Chief Financial Officer
linkedin
leader-logo
Carole Huntsman
Chief Commercial Officer (CCO)
linkedin
Company data provided by crunchbase